24/7 Wall St.

PDL BioPharma, Inc. (NASDAQ: PDLI) appears to have a new royalty stream coming its way.  The company announced this morning that it is now set to start receiving royalty payments from Roche’s Genentech unit on sales of Pertuzumab.

Genentech has now notified PDL that Pertuzumab, which will be marketed under the brand name Perjeta, is a royalty license product.  Under the deal, PDL is set to receive royalties on sales of Perjeta in the quarter following the first quarter of Perjeta sales as per the contract which exists under Genentech’s license agreements with PDL.

PDL said that it anticipates that Perjeta will enter the market later this month. Here is why this matters. In February 2012, Roche forecast sales of more than $1 billion for pertuzumab when approved. Here was the data during the last quarterly update for the fourth quarter:

  • In December, Roche and Genentech filed regulatory…

View original post 187 more words


About heloise8

Meaning of "trough" -- Trough is the bottom of a transverse wave. And generically means a low point or a place to fill. Venus is related to this meaning. Veins are to be filled, and venusian people are loving. The left is more venusian than the right, hence The Trough--where Heloise helps the great and the small. Heloise the politico from Blogcritics.org. Physics preacher, blogger, gardener, beach lover, book lover, writer, author.

Posted on July 4, 2012, in Uncategorized. Bookmark the permalink. Leave a comment.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s